Federated Hermes Inc. Has $6.42 Million Holdings in Nu Skin Enterprises, Inc. (NYSE:NUS)

Federated Hermes Inc. lifted its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 29,649.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 330,812 shares of the company's stock after purchasing an additional 329,700 shares during the period. Federated Hermes Inc. owned 0.67% of Nu Skin Enterprises worth $6,424,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. DGS Capital Management LLC bought a new stake in Nu Skin Enterprises during the fourth quarter valued at approximately $367,000. Strs Ohio grew its position in shares of Nu Skin Enterprises by 13.1% in the 4th quarter. Strs Ohio now owns 36,200 shares of the company's stock worth $703,000 after buying an additional 4,200 shares during the period. Louisiana State Employees Retirement System purchased a new stake in shares of Nu Skin Enterprises in the 4th quarter worth about $480,000. Harbor Capital Advisors Inc. grew its position in shares of Nu Skin Enterprises by 57.7% in the 4th quarter. Harbor Capital Advisors Inc. now owns 16,592 shares of the company's stock worth $322,000 after buying an additional 6,069 shares during the period. Finally, Gladius Capital Management LP bought a new position in Nu Skin Enterprises in the 3rd quarter worth about $178,000. 82.84% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on NUS shares. DA Davidson lowered their target price on shares of Nu Skin Enterprises from $29.00 to $21.00 and set a "neutral" rating on the stock in a research note on Friday, January 5th. StockNews.com lowered shares of Nu Skin Enterprises from a "buy" rating to a "hold" rating in a report on Saturday, February 24th. Four equities research analysts have rated the stock with a hold rating, According to MarketBeat.com, Nu Skin Enterprises presently has a consensus rating of "Hold" and a consensus price target of $23.67.

Nu Skin Enterprises Price Performance

Shares of NUS stock traded up $0.07 on Friday, reaching $12.32. The company's stock had a trading volume of 429,626 shares, compared to its average volume of 749,536. The company has a market capitalization of $608.61 million, a price-to-earnings ratio of 68.28 and a beta of 1.11. The stock's fifty day simple moving average is $12.76 and its 200-day simple moving average is $16.35. Nu Skin Enterprises, Inc. has a 1 year low of $11.84 and a 1 year high of $40.68. The company has a current ratio of 2.13, a quick ratio of 1.28 and a debt-to-equity ratio of 0.58.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last issued its quarterly earnings results on Wednesday, February 14th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.29 by $0.08. Nu Skin Enterprises had a return on equity of 10.73% and a net margin of 0.44%. The company had revenue of $488.64 million during the quarter, compared to the consensus estimate of $479.35 million. Analysts forecast that Nu Skin Enterprises, Inc. will post 1.13 earnings per share for the current fiscal year.

Nu Skin Enterprises Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 6th. Stockholders of record on Monday, February 26th were paid a dividend of $0.06 per share. The ex-dividend date of this dividend was Friday, February 23rd. This represents a $0.24 dividend on an annualized basis and a dividend yield of 1.95%. Nu Skin Enterprises's payout ratio is 133.34%.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.